Hervycta 150 mg Injection
253,25$
128,16$
Hervycta 150 mg injection is a specialized treatment designed for individuals battling metastatic breast cancer and metastatic gastric cancer. As a targeted monoclonal antibody, it specifically inhibits the HER2/neu receptor, which is often overexpressed in certain cancer cells. By precisely focusing on these tumor cells, Hervycta effectively halts their growth and prevents further reproduction, offering a vital option in cancer therapy. While this medication can significantly impact the progression of these cancers, patients should be aware of potential side effects, including common reactions at the injection site and systemic effects. It is crucial to discuss any existing health conditions and medications with a healthcare provider before starting treatment with Hervycta. This ensures a tailored approach to managing your cancer therapy safely and effectively. By integrating Hervycta into your treatment plan, you take a proactive step toward combating these challenging forms of cancer. Always follow your healthcare professional's guidance for optimal results and safety during your treatment journey.
Cantidad
Active Pharmaceutical Ingredient
Uses
• Hervycta 150 mg injection is utilized in the treatment of specific types of cancer, particularly those that express the HER2 protein. This medication works by targeting and inhibiting the growth of cancer cells, thereby potentially slowing disease progression. It is often prescribed for patients who have not responded to other treatment options. Administered under medical supervision, it ensures that patients receive the appropriate care and monitoring.
• This injection is particularly beneficial for individuals diagnosed with breast cancer that is HER2-positive. Hervycta 150 mg injection helps in managing the disease by specifically attacking the HER2 receptors on cancer cells. This targeted approach can enhance treatment efficacy and improve patient outcomes. Healthcare providers typically recommend this therapy as part of a comprehensive treatment plan.
• Hervycta 150 mg injection is also indicated for use in certain gastrointestinal cancers that overexpress HER• By directly interfering with the signaling pathways that promote cancer cell growth, it can provide a meaningful therapeutic option for these patients. The administration of this injection is carefully managed in a hospital setting to ensure safety and effectiveness. It is often combined with other therapies to maximize treatment benefits.
• In addition to its role in treating various cancers, Hervycta 150 mg injection may be part of clinical trials exploring new treatment protocols. Patients may receive this medication as part of an innovative approach to cancer therapy. Participation in such trials can provide access to cutting-edge treatments while contributing to ongoing medical research. The use of Hervycta in these scenarios highlights its importance in advancing cancer care.
Benefits
Breast cancer: Hervycta 150 mg Injection is used for the treatment of breast cancer when there has been no significant improvement with other medicines. It helps stop the growth and spread of the cancer, and relieves symptoms of breast cancer, such as lumps in the breast, nipple discharge, or changes in the shape or texture of the breast. A doctor or nurse will give this medicine by injection. To get the most benefit, follow your doctor's instructions carefully.
Stomach cancer: Stomach cancer, also known as gastric cancer, can occur in the inner lining (called the lining) of the stomach or in the walls of the stomach. There are different types of stomach cancer depending on where it starts, the area affected and the severity of the cancer. Hervycta 150 mg helps kill cancer cells and stop them from growing and spreading. To get the most benefit, follow your doctor's instructions carefully.
Side Effects
Like all medicines, Hervycta 150 mg Injection may cause side effects that do not require medical attention and which will disappear as your body adjusts to the medicine. Tell your doctor if they persist or if you're worried about them.
Most Common Side Effects
• Infection
• Fever
• Weight Loss
• Appetite Loss
• Skin Rashes
• Constipation
• Reduce in Blood Count
• Heartburn
• Runny Nose
• Hair Loss
• Muscle and Joint Pain
Common Side Effects
• congestive heart failure
• Lung problems
• trouble in breathing
• fluid in the lungs
How To Use
Hervycta Injection is an intravenous infusion, administered under the supervision of your doctor or a nurse in a hospital. Self-administration is not recommended to the patient.
Safety Advice
• Alcohol: Drinking alcohol while taking Hervycta 150 Injection is generally not recommended. It may increase the risk of liver damage. It is best to avoid alcohol or limit your alcohol intake while taking any medication.
• Kidney: It is safe to use Hervycta Injection in patients with kidney disease. No dose adjustment of Hervycta 150 mg Injection is recommended. If you experience any side effects, please consult your doctor.
• Breastfeeding: It is not recommended to breastfeed while taking Hervycta 150 Injection. Hervycta 150 mg may pass into breast milk and harm the infant. If you are breastfeeding and taking Hervycta 150 mg Injection, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Hervycta Injection is safe for use in patients with mild to moderate liver disease, no dose adjustment of Hervycta 150 mg Injection is recommended. The use of Hervycta 150 mg Injection is not recommended for severe liver disease patients. It is important to discuss all of your medical conditions and medications with your doctor to ensure that the treatment plan is safe and effective for you.
• Pregnancy: Use of Hervycta 150 mg Injection may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Hervycta Injection during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Hervycta 150 mg may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this Hervycta 150 Injection.